EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Machine Learning-Assisted Drug Repurposing Framework for Discovery of Aurora Kinase B Inhibitors

George Nicolae Daniel Ion iD, George Mihai Nitulescu iD, Dragos Paul Mihai iD

Pharmaceuticals · 25.12.2024 · 18 (1) · 13

DOI: 10.3390/ph18010013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 25.12.2024. Verfasst von George Nicolae Daniel Ion und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Aurora kinase B (AurB) is a pivotal regulator of mitosis, making it a compelling target for cancer therapy. Despite significant advances in protein kinase inhibitor development, there are currently no AurB inhibitors readily available for therapeutic use.

Methods

This study introduces a machine learning-assisted drug repurposing framework integrating quantitative structure-activity relationship (QSAR) modeling, molecular fingerprints-based classification, molecular docking, and molecular dynamics (MD) simulations. Using this pipeline, we analyzed 4680 investigational and approved drugs from DrugBank database.

Results

The machine learning models trained for drug repurposing showed satisfying performance and yielded the identification of saredutant, montelukast, and canertinib as potential AurB inhibitors. The candidates demonstrated strong binding energies, key molecular interactions with critical residues (e.g., Phe88, Glu161), and stable MD trajectories, particularly saredutant, a neurokinin-2 (NK2) antagonist.

Conclusions

Beyond identifying potential AurB inhibitors, this study highlights an integrated methodology that can be applied to other challenging drug targets.

Schlagwörter

Stichwörter der Autor:innen

AURKBQSARcancer therapyclassification modelscomputer-aided drug design and discoveryinteraction fingerprintsprotein kinase inhibitionvirtual screening

Autor:innen und Institutionen

  • Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania.

ORCID-Profile: George Nicolae Daniel Ion, George Mihai Nitulescu, Dragos Paul Mihai

Zitieren

APA

Ion, G. N. D., Nitulescu, G. M., & Mihai, D. P. (2024). Machine Learning-Assisted Drug Repurposing Framework for Discovery of Aurora Kinase B Inhibitors. Pharmaceuticals, 18(1), 13. https://doi.org/10.3390/ph18010013

Vancouver

Ion GND, Nitulescu GM, Mihai DP. Machine Learning-Assisted Drug Repurposing Framework for Discovery of Aurora Kinase B Inhibitors. Pharmaceuticals. 2024;18(1):13. doi:10.3390/ph18010013

BibTeX
@article{Ion2024,
  author = {Ion, George Nicolae Daniel and Nitulescu, George Mihai and Mihai, Dragos Paul},
  title = {Machine Learning-Assisted Drug Repurposing Framework for Discovery of Aurora Kinase B Inhibitors},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {18},
  number = {1},
  pages = {13},
  doi = {10.3390/ph18010013}
}
Kostenlos starten →